Caplight Directory>Companies>Phiogen-preview>Phiogen


Phiogen

Phiogen

Private
Houston, TexasN/Ahttps://phiogen.com/

Last Round

Grant

Aug 26, 2025

Total Funding Raised

$1.1M

Company Overview

Phiogen is a biotechnology company that develops a platform to generate next-generation therapeutics utilizing bacteriophages for broad patient applications.

Keywords

bacteriophage therapeuticsphage therapyantimicrobial resistanceAMRdrug-resistant infectionssuperbugsphage discovery platformoff-the-shelf therapeuticsantibiotic alternativespreclinical biotechnologyrecurrent urinary tract infectionsrUTIsdirected evolutionbloodstream infectionsbacteremiadrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phiogen Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Phiogen Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantAug 26, 2025
AcceleratorSep 11, 2024
SeedJan 1, 2023
AcceleratorJan 28, 2022
View all Funding Rounds

Phiogen Investors

Notable investors and investment history

InvestorRounds
CARB-XGrant
INCATEAccelerator
Springboard EnterprisesAccelerator
BCM VenturesSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 26, 2025

    $1.1M grant awarded by CARB-X.

  • Sep 11, 2024

    Participated in an accelerator round with Springboard Enterprises.

View all signals

Phiogen Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Phiogen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phiogen's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Year Founded2023
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.